Working With the Body, Not Around It.
A biomimetic scaffold built from the patient’s own blood, held in place by a structural cage, giving bone a framework to grow back across a gap it could not close alone.
The Process
Six Stages, One Continuous Story.
Scroll through the sequence — the diagram on the right follows along.
A defect too large for the body to bridge on its own
0101The Problem: A Gap in the Bone
When a segment of bone is lost to trauma, infection or resection, the two ends can no longer find each other. Left alone, the gap does not close.
The cage stabilises the space between the segments
0202A Scaffold to Span It
A structural cage bridges and stabilises the defect, holding the space open so regeneration has somewhere to happen and the limb keeps its shape.
Blood becomes a cohesive biomimetic matrix
0303The Patient’s Own Biology
The patient’s blood is processed into a cohesive, handleable material — a biomimetic matrix that mirrors the body’s own architecture, with cells held within it.
The matrix fills the cavity between the bone ends
0404Placed Into the Defect
The material is deposited into the cage, where it expands to fill the cavity and sit in direct contact with both bone ends.
Regenerative activity spreads through the matrix
0505A Healing Environment
Inside the scaffold, cells have a natural framework to grow into. In VitaClot+, BMP-2 is delivered throughout the matrix — inside and outside — for more challenging defects.
New bone connects the two segments
0606The Bridge Restored
New bone progressively connects the two segments and the scaffold recedes into the background as the restored structure takes over.
A defect too large for the body to bridge on its own
01Stage 01 of 06
One Platform. Two Configurations.
The same biomimetic approach, offered in two forms so it can meet different clinical needs.
- Blood-based, biomimetic matrix
- Cells integrated within the scaffold
- Designed for bone repair
- Cells integrated within the scaffold
- BMP-2 delivered throughout the scaffold (inside and outside)
- Designed for more challenging bone defects
Real-World Experience. Growing Evidence.
The technology has been used in over 140 patient cases, with encouraging clinical outcomes, supported by a growing body of peer-reviewed publications.
- Patient Cases
- 140+
- Patient Cases
- Peer-Reviewed Publications
- 20+
- Peer-Reviewed Publications
- Clinical Indications
- Multiple
- Clinical Indications
- Clinical Studies
- Ongoing
- Clinical Studies
Partner with Us to Bring Better Healing to More Patients.
We are seeking strategic partners and investors to advance VitaClot and VitaClot+ to market.